ArticleOPEN ACCESS

Erratum: A pharmacology perspective on simultaneous tuberculosis and hepatitis C treatment (Antimicrobial Agents and Chemotherapy (2019) 63:12 (e01215-19) DOI: 10.1128/AAC.01215-19)

Antimicrobial Agents and Chemotherapy
DOI: 10.1128/AAC.02358-19
0Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Volume 63, no. 12, e01215-19, 2019, https://doi.org/10.1128/AAC.01215-19. Page 7 of the PDF, 3rd full paragraph, 1st sentence: The combination of elbasvir and grazoprevir is approved for HCV genotypes 1 to 4 should read "The combination of elbasvir and grazoprevir is approved for HCV genotypes 1 and 4. .

Cite

CITATION STYLE

APA

Kempker, R. R., Alghamdi, W. A., Al-Shaer, M. H., Burch, G., & Peloquin, C. A. (2020, January 27). Erratum: A pharmacology perspective on simultaneous tuberculosis and hepatitis C treatment (Antimicrobial Agents and Chemotherapy (2019) 63:12 (e01215-19) DOI: 10.1128/AAC.01215-19). Antimicrobial Agents and Chemotherapy. American Society for Microbiology. https://doi.org/10.1128/AAC.02358-19

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free